Target intelligence / Profile preview

Origin recognition complex subunit 2 (ORC2)

Target
ORC2
Molecular classification
Other (subunit of multi-protein DNA replication complex)
01

Overview

Origin recognition complex subunit 2 (ORC2) is one of the six subunits of the highly conserved origin recognition complex (ORC), which is essential for the initiation of DNA replication in eukaryotes. ORC2 helps ORC bind to replication origins in an ATP-dependent manner and serves as a platform for the assembly of additional initiation factors such as Cdc6 and the MCM helicase complex[1][3][5]. ORC2 is also implicated in non-replicative functions, including heterochromatin formation, maintenance of centromeric histone methylation, chromosome segregation, centrosome duplication, and mRNA nuclear export[5]. Mutations in ORC2 can cause microcephalic primordial dwarfism (Meier-Gorlin syndrome) and are associated with certain immunodeficiency syndromes[2][3]. Currently, ORC2 itself is not targeted by approved or experimental drugs and is not considered a drug target or receptor, although disruption can affect pathways commonly altered in cancer and developmental disease[3][5].

Other names
ORC2Lorigin recognition complex protein 2 homologorigin recognition complex, subunit 2 homolog
02

Biological functions

DNA replication initiationCell cycle regulationChromosome segregationHeterochromatin formationmRNA nuclear export
03

Disease associations

CancerMicrocephalic primordial dwarfism (Meier-Gorlin syndrome)Immunodeficiency (e.g., T-cell immunodeficiency with thymic aplasia)Fanconi anemia (complementation group D2)
04

Safety considerations

Genomic instability if disruptedPotential developmental defects (mutations linked to Meier-Gorlin syndrome)

Beyond the preview

Go deeper on Origin recognition complex subunit 2 (ORC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Origin recognition complex subunit 2 (ORC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call